A Trial of Chemotherapy Before and After Surgery for Stage II,III Esophageal Squamous Cell Carcinoma

NCT00190554 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

330

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Neoplasms
Carcinoma, Squamous Cell

Interventions

DRUG: Surgery +(Cisplatin 80 mg/㎡+5FU 800mg/㎡×5days)×2
DRUG: (Cisplatin 80 mg/㎡+5FU 800mg/㎡×5days)×2＋Surgery

Sponsor

Japan Clinical Oncology Group

Collaborators

[object Object]